Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neuroscience

• Publication date

  2002-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1523/JNEUROSCI.22-08-03234.2002PMID 11943824PMCID PMC6757538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains

  2004cited by this paper
• Progressive age-related impairment of cognitive behavior in APP23 transgenic mice.

  2003cited by this paper
• Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice

  2002cited by this paper
• β-Amyloid1–42 Peptide Directly Modulates Nicotinic Receptors in the Rat Hippocampal Slice

  2001cited by this paper
• Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes

  2001cited by this paper
• Pathogenesis and Mechanism of Cerebral Amyloidosis in APP Transgenic Mice

  2001cited by this paper
• Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.

  2001cited by this paper
• Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

  2001cited by this paper
• Protofibrils, the unifying toxic molecule of neurodegenerative disorders?

  2001cited by this paper
• Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains*

  2001influential reference
• Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert

  2000cited by this paper
• Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

  2000cited by this paper
• Brain trauma in aged transgenic mice induces regression of established abeta deposits.

  2000cited by this paper
• Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition.

  2000cited by this paper
• Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice.

  2000cited by this paper
• Brain Trauma in Aged Transgenic Mice Induces Regression of Established Aβ Deposits

  2000cited by this paper
• The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

  2000influential reference
• Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition

  2000influential reference
• Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes

  1999influential reference
• Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.

  1999cited by this paper
• Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice

  1999cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.

  1999cited by this paper
• Microtechnology: Laying it on thick

  1999cited by this paper
• Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

  1999influential reference
• Microglial response to amyloid plaques in APPsw transgenic mice.

  1998cited by this paper
• Pharmacological Drug Treatment of Alzheimer Disease: The Cholinergic Hypothesis Revisited

  1998cited by this paper
• Neuron loss in APP transgenic mice

  1998cited by this paper
• Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology.

  1998cited by this paper
• Dose‐dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease

  1998cited by this paper
• Relationship Between Plaques, Tangles, and Loss of Cortical Cholinergic Fibers in Alzheimer Disease

  1998influential reference
• Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice.

  1998influential reference
• β-Amyloid peptides as direct cholinergic neuromodulators: a missing link?

  1998cited by this paper
• Amyloid, the presenilins and Alzheimer's disease.

  1997cited by this paper
• Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain.

  1997cited by this paper
• In Vivo Regulation of Amyloid Precursor Protein Secretion in Rat Neocortex by Cholinergic Activity

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997influential reference
• Cholinergic activity and amyloid precursor protein metabolism.

  1997cited by this paper
• Alzheimer's disease: genotypes, phenotypes, and treatments.

  1997cited by this paper
• Improved electrophoretic separation and immunoblotting of beta‐amyloid (Aβ) peptides 1–40, 1–42, and 1–43

  1997cited by this paper
• Alzheimer's Disease--Genotypes, Phenotype, and Treatments

  1997cited by this paper
• Expression of the neural adhesion molecule L1 in the deafferented dentate gyrus.

  1996cited by this paper
• Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Electrophoretic separation of betaA4 peptides (1-40) and (1-42).

  1996influential reference
• Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease

  1996cited by this paper
• Expression of APP in transgenic mice: a comparison of neuron-specific promoters.

  1996cited by this paper
• Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

  1996cited by this paper
• Effect of alkalizing agents on the processing of the beta-amyloid precursor protein.

  1996cited by this paper
• Electrophoretic Separation of βA4 Peptides (1–40) and (1–42)

  1996influential reference
• The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease.

  1996cited by this paper
• An unbiased method for estimation of total epidermal nerve fibre length

  1996influential reference
• Effect of alkalizing agents on the processing of the β-amyloid precursor protein

  1996cited by this paper
• Essential role of neocortical acetylcholine in spatial memory

  1995cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits

  1995cited by this paper
• Cholinergic innervation of mouse forebrain structures

  1994cited by this paper
• Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert.

  1994cited by this paper
• Inactivation of a tumor suppressor function in immortal Syrian hamster cells by N-methyl-N'-nitro-N-nitrosoguanidine and by 5-aza-2'-deoxycytidine.

  1993cited by this paper
• Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease

  1993cited by this paper
• New stereological methods for counting neurons.

  1993cited by this paper
• Activation of protein kinase C inhibits cellular production of the amyloid beta-protein.

  1993cited by this paper
• Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques.

  1993cited by this paper
• The rotator

  1993cited by this paper
• Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.

  1992cited by this paper
• Alzheimer's disease: Is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?

  1992cited by this paper
• Cholinesterases in the amyloid angiopathy of Alzheimer's disease

  1992cited by this paper
• Estimating neuron dendritic length in 3D from total vertical projections and from vertical slices

  1992cited by this paper
• Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations

  1992cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor.

  1992cited by this paper
• Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.

  1992cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Convergent cholinergic activities in aging and Alzheimer's disease.

  1992cited by this paper
• Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.

  1992cited by this paper
• Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

  1991influential reference
• Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.

  1990cited by this paper
• Cortical projection patterns of the medial septum‐diagonal band complex

  1990cited by this paper
• A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease.

  1989cited by this paper
• Some new, simple and efficient stereological methods and their use in pathological research and diagnosis

  1988cited by this paper
• Animal models of Alzheimer's disease: experimental cholinergic denervation.

  1988cited by this paper
• Cholinergic function and intellectual decline in Alzheimer's disease.

  1986cited by this paper
• A modified histochemical technique to visualize acetylcholinesterase-containing axons.

  1985cited by this paper
• Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

  1984cited by this paper
• An Immunological Study of Rat Acetylcholinesterase: Comparison with Acetylcholinesterases from Other Vertebrates

  1984cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983influential reference
• Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage.

  1983cited by this paper
• Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system

  1983influential reference
• Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.

  1981cited by this paper
• Decrease of neocortical choline acetyltransferase after lesion of the globus pallidus in the rat.

  1978influential reference
• A rapid radiochemical method for the determination of choline acetyltransferase

  1975cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Selective vulnerability of the aging cholinergic system to amyloid pathology revealed by induced APP overexpression

  2026cites this paper
• Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

  2024cites this paper
• Advancing Alzheimer’s Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies

  2024cites this paper
• Loss of Cholinergic and Monoaminergic Afferents in APPswe/PS1ΔE9 Transgenic Mouse Model of Cerebral Amyloidosis Preferentially Occurs Near Amyloid Plaques

  2024influential citation
• Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.

  2023cites this paper
• Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome

  2023cites this paper
• Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline

  2023cites this paper
• Receptor-based approaches and therapeutic targets in Alzheimer’s disease along with role of AI in drug designing: Unraveling pathologies and advancing treatment strategies

  2023cites this paper
• Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease

  2022cites this paper
• Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis

  2022cites this paper
• Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease

  2021cites this paper
• Cholinergic neurodegeneration in Alzheimer disease mouse models.

  2021cites this paper
• Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.

  2021cites this paper
• Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.

  2021cites this paper
• Therapeutic Potential of Mangiferin in the Treatment of Various Neuropsychiatric and Neurodegenerative Disorders.

  2020cites this paper
• The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (Aβ) peptide.

  2020cites this paper
• Behavioural and psychological symptoms of dementia in mouse models of Alzheimer's disease-related pathology: Running title: BPSD in Alzheimer's disease models.

  2020cites this paper
• Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease

  2020cites this paper
• Anesthesia and Alzheimer's: A review

  2020cites this paper
• Basal forebrain atrophy along the Alzheimer’s disease spectrum and its relevance for subjective cognitive decline

  2020cites this paper
• Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models

  2020cites this paper
• Nerve growth factor metabolic dysfunction contributes to sevoflurane-induced cholinergic degeneration and cognitive impairments.

  2019cites this paper
• Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.

  2019cites this paper
• Alzheimer’s disease: Neurotransmitters of the sleep-wake cycle

  2019cites this paper
• Alzheimer's disease: neurotransmitters of the sleep-wake cycle.

  2019cites this paper
• The effect of cholinergic loss on the structure and function of the neurovascular unit: implications for cerebral amyloid angiopathy

  2019cites this paper
• The Value of the Object Recognition Paradigm in Investigating Animal Models of Alzheimer's Disease: Advances and Future Directions

  2018cites this paper
• Amyloid beta-peptide ( 1-42 ) induced neurotoxicity in experimental rats : Effect of Donepezil

  2018cites this paper
• Trigonelline Ameliorates Learning and Memory and Synaptic Plasticity Impairment in Intrahippocampal Amyloid Beta (1-40) Rat Model of Alzheimer’s Disease

  2018influential citation
• Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology

  2018cites this paper
• In Vivo Volumetry of the Cholinergic Basal Forebrain

  2018cites this paper
• The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer’s Disease Neuropathology

  2017cites this paper
• Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer’s Disease

  2017cites this paper
• Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints.

  2017cites this paper
• Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons

  2017cites this paper
• Maternal separation exacerbates Alzheimer's disease‐like behavioral and pathological changes in adult APPswe/PS1dE9 mice

  2017cites this paper
• Cholinergic degeneration in early stages of Alzheimer’s disease: Loss of cholinergic phenotype or loss of cells?

  2017cites this paper
• Aging, microglia and cytoskeletal regulation are key factors in the pathological evolution of the APP23 mouse model for Alzheimer's disease.

  2017cites this paper
• Cognitive and Non-Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease

  2017cites this paper
• Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.

  2016cites this paper
• Erratum to: Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice

  2016cites this paper
• Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.

  2016cites this paper
• Rutin as a Natural Therapy for Alzheimer's Disease: Insights into its Mechanisms of Action.

  2016cites this paper
• The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.

  2016cites this paper
• Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein

  2016cites this paper
• Donepezil modulates the endogenous immune response: implications for Alzheimer's disease

  2016cites this paper
• REVIEWS: CURRENT TOPICS The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease

  2016cites this paper
• Dissecting Alzheimer disease in Down syndrome using mouse models

  2015cites this paper
• Investigating the impact of anaesthesia and surgery on Alzheimer's disease and the potential therapeutic role of Statin

  2015cites this paper
• The structural plasticity of dendritic spines in amyloid precursor protein transgenic and knockout mouse models

  2015cites this paper
• Implication des recepteurs nicotiniques α7 dans les deficits mnesiques induits par des injections intra-hippocampiques de peptides amyloïdes-beta (1-42) chez la souris

  2015cites this paper
• Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice

  2015cites this paper
• IC‐P‐105: Basal forebrain and hippocampus as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment: A multicenter DTI and volumetry study

  2015cites this paper
• Investigating contributions of trisomy 21 in Down syndrome to Alzheimer disease phenotypes in a novel mouse cross

  2015cites this paper
• Phagocytes mononucléaires dans la maladie d'Alzheimer : caractérisation et stimulation de mécanismes cellulaires promouvant l'élimination de bêta-amyloïde

  2015cites this paper
• Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease

  2015cites this paper
• Limited Effects of an eIF2α S51A Allele on Neurological Impairments in the 5xFAD Mouse Model of Alzheimer's Disease

  2015cites this paper
• Alzheimer Diseases

  2015cites this paper
• Ectodermal Differentiation of Wharton's Jelly Mesenchymal Stem Cells for Tissue Engineering and Regenerative Medicine Applications

  2014cites this paper
• Protective Effects of Borago officinalis Extract on Amyloid β-Peptide(25–35)-Induced Memory Impairment in Male Rats: A Behavioral Study

  2014cites this paper
• Immunolesion‐induced loss of cholinergic projection neurones promotes β‐amyloidosis and tau hyperphosphorylation in the hippocampus of triple‐transgenic mice

  2014cites this paper
• Interactions between Aβ oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacities.

  2014cites this paper
• Fatty Acids and the Aging Brain

  2014cites this paper
• Topographic Mapping between Basal Forebrain Cholinergic Neurons and the Medial Prefrontal Cortex in Mice

  2014cites this paper
• Chronic Neuroinflammation in Alzheimer's Disease: New Perspectives on Animal Models and Promising Candidate Drugs

  2014cites this paper
• Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

  2014cites this paper
• Complete morphologies of basal forebrain cholinergic neurons in the mouse

  2014influential citation
• Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects

  2014cites this paper
• Genetic mouse models of brain ageing and Alzheimer's disease.

  2014cites this paper
• Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia.

  2013cites this paper
• Glycogen synthase kinase-3 reduces acetylcholine level in striatum via disturbing cellular distribution of choline acetyltransferase in cholinergic interneurons in rats.

  2013cites this paper
• Early Endosomal Abnormalities and Cholinergic Neuron Degeneration in Amyloid-β Protein Precursor Transgenic Mice

  2013influential citation
• Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU.

  2013cites this paper
• Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.

  2013cites this paper
• The Amyloid Precursor Protein Represses Expression of Acetylcholinesterase in Neuronal Cell Lines*

  2013cites this paper
• Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease

  2013influential citation
• The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?

  2013cites this paper
• Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model.

  2012cites this paper
• The Basal Forebrain Cholinergic Projection System in Mice Neuron Types in the Basal Forebrain - Chapter 28 The Mouse Nervous System

  2012influential citation
• Early Increases in Soluble Amyloid-β Levels Coincide with Cholinergic Degeneration in 3xTg-AD Mice

  2012cites this paper
• Automated measurement of nerve fiber density using line intensity scan analysis.

  2012influential citation
• Alzheimer's Disease and Metals: A Review of the Involvement of Cellular Membrane Receptors in Metallosignalling

  2011cites this paper
• Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology?

  2011cites this paper
• Embryonic Stem Cell in the Therapy of Neurodegenerative Diseases

  2011cites this paper
• The Flavonoid Apigenin Protects Brain Neurovascular Coupling against Amyloid-β25-35-Induced Toxicity in Mice

  2011cites this paper
• Genetic mouse models of neurodegenerative diseases.

  2011cites this paper
• Interactions of AChE with Aβ Aggregates in Alzheimer’s Brain: Therapeutic Relevance of IDN 5706

  2011cites this paper
• Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23.

  2011cites this paper
• Rapid communication Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model

  2011cites this paper
• Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

  2011cites this paper
• ENRIQUECIMIENTO AMBIENTAL EN RATONES 3xTgAD

  2011cites this paper
• Age and gene overexpression interact to abolish nesting behavior in Tg2576 amyloid precursor protein (APP) mice.

  2011cites this paper
• Animal Models of Neurodegenerative Diseases

  2011cites this paper
• ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE

  2010influential citation
• Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.

  2010cites this paper
• Vieillissement olfactif chez la souris normale et chez la souris APP/PS1, modèle de la maladie d'Alzheimer : implications de la neurogenèse et du système noradrénergique

  2010cites this paper
• Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.

  2010cites this paper
• Cholinesterase activity in brain of senescence‐accelerated‐resistant mouse SAMR1 and its variation in brain of senescence‐accelerated‐prone mouse SAMP8

  2010cites this paper
• Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice

  2010cites this paper
• Animal models of neurological disease.

  2010cites this paper